Skip to main content

Lidocaine

NDC 50804-756 · Perrigo Direct

Generic nameBurn Relief
Dosage formAEROSOL, SPRAY
RouteTOPICAL
Active ingredient(s)LIDOCAINE
Strength.64 g/127g
Pharmacologic classAmide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
Marketing categoryOTC MONOGRAPH DRUG

Packages

50804-756-45 — 127 g in 1 CAN (50804-756-45)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-7857 — Lidocaine 5%, 50090-7894 — Lidocaine, 50090-7922 — lidocaine, 50090-8011 — Lidocaine, 50332-0037 — benzalkonium chloride, lidocaine, 50332-0091 — benzalkonium chloride, lidocaine, 50332-0217 — benzethonium chloride and lidocaine, 50488-1001 — Lidocaine, Menthol, 50488-2004 — Lidocaine, 50804-317 — Glycerin, Lidocaine, Petrolatum, Phenylephrine HCl, 50804-838 — Lidocaine, 51028-004 — Lidocaine 4%, 51142-100 — lidocaine, 51142-101 — lidocaine, 51316-100 — Lidocaine, 51316-225 — GLYCERIN, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE, WHITE PETROLATUM, 51316-226 — LIDOCAINE, 51316-229 — LIDOCAINE, 51316-231 — Lidocaine, 51316-274 — Lidocaine, Menthol, +874 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels